Igenomix Competitors and Similar CompaniesClear all
23andMe's competitors and similar companies include Blueprint Genetics and OmeCare.
 23andMe 23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company. |  Blueprint Genetics Blueprint Genetics provides clinical gene testing and customized next-generation sequencing services. |  OmeCare OmeCare (formerly known as Pathway Genomics) is a clinical diagnostic and mobile healthcare technology company. | |
Founding Date | Founding Date 2006 | Founding Date 2012 | Founding Date 2009 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Sunnyvale, US HQ South San Francisco, US | Locations Esbo, FI HQ Dubai, AE Seattle, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 56027% decrease | Employees 2191% decrease | Employees 6 |
Valuation ($) | Valuation ($) 169.1 m | Valuation ($) N/A | Valuation ($) 932.7 m |
Financial | |||
Revenue (est.) | Revenue (est.) $189.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $14.4m (FY, 2013) |
Operating ⚠ | |||
Countries | Countries 50 (Apr, 2020) | Countries N/A | Countries 40 (Jan, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 912.5m | Total funding raised $ 26.3m | Total funding raised $ 127.2m |
For sources of this data, please see the company profile
View Company Profiles
Blueprint Genetics
HQ
Esbo, FI
Employees
219↓ 1% decrease
Blueprint Genetics provides clinical gene testing and customized next-generation sequencing services.
View companyOmeCare
HQ
San Diego, US
Employees
6
OmeCare (formerly known as Pathway Genomics) is a clinical diagnostic and mobile healthcare technology company.
View company